Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

285 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Effect of sibutramine on cardiovascular outcomes in overweight and obese subjects.
James WP, Caterson ID, Coutinho W, Finer N, Van Gaal LF, Maggioni AP, Torp-Pedersen C, Sharma AM, Shepherd GM, Rode RA, Renz CL; SCOUT Investigators. James WP, et al. N Engl J Med. 2010 Sep 2;363(10):905-17. doi: 10.1056/NEJMoa1003114. N Engl J Med. 2010. PMID: 20818901 Free article. Clinical Trial.
Acute effect of weight loss on levels of total bilirubin in obese, cardiovascular high-risk patients: an analysis from the lead-in period of the Sibutramine Cardiovascular Outcome trial.
Andersson C, Weeke P, Fosbøl EL, Brendorp B, Køber L, Coutinho W, Sharma AM, Van Gaal L, Finer N, James WP, Caterson ID, Rode RA, Torp-Pedersen C; SCOUT Executive Steering Committee; SCOUT investigators. Andersson C, et al. Among authors: james wp. Metabolism. 2009 Aug;58(8):1109-15. doi: 10.1016/j.metabol.2009.04.003. Epub 2009 Jun 18. Metabolism. 2009. PMID: 19454355 Clinical Trial.
Association of hypoglycemic treatment regimens with cardiovascular outcomes in overweight and obese subjects with type 2 diabetes: a substudy of the SCOUT trial.
Ghotbi AA, Køber L, Finer N, James WP, Sharma AM, Caterson I, Coutinho W, Van Gaal LF, Torp-Pedersen C, Andersson C. Ghotbi AA, et al. Among authors: james wp. Diabetes Care. 2013 Nov;36(11):3746-53. doi: 10.2337/dc13-0027. Epub 2013 Oct 2. Diabetes Care. 2013. PMID: 24089540 Free PMC article. Clinical Trial.
Relation between weight loss and causes of death in patients with cardiovascular disease: finding from the SCOUT trial.
Maggioni AP, Caterson ID, Urso R, Coutinho W, Finer N, Van Gaal L, Legler UF, Sharma AM, Seimon RV, Sweeting A, Torp-Pedersen C, James WP. Maggioni AP, et al. Among authors: james wp. J Cardiovasc Med (Hagerstown). 2017 Mar;18(3):144-151. doi: 10.2459/JCM.0000000000000492. J Cardiovasc Med (Hagerstown). 2017. PMID: 28002198 Clinical Trial.
Sibutramine: balanced judgment or prejudice?
Coutinho W, James WP. Coutinho W, et al. Among authors: james wp. Braz J Psychiatry. 2011 Jun;33(2):115-6. doi: 10.1590/s1516-44462011000200004. Braz J Psychiatry. 2011. PMID: 21829902 Free article. No abstract available.
Predictors of weight loss and maintenance during 2 years of treatment by sibutramine in obesity. Results from the European multi-centre STORM trial. Sibutramine Trial of Obesity Reduction and Maintenance.
Hansen D, Astrup A, Toubro S, Finer N, Kopelman P, Hilsted J, Rössner S, Saris W, Van Gaal L, James W, Goulder M; STORM Study Group. Hansen D, et al. Int J Obes Relat Metab Disord. 2001 Apr;25(4):496-501. doi: 10.1038/sj.ijo.0801481. Int J Obes Relat Metab Disord. 2001. PMID: 11319653 Clinical Trial.
A Dissenter's Journey.
James WPT. James WPT. Annu Rev Nutr. 2021 Oct 11;41:1-18. doi: 10.1146/annurev-nutr-101220-114101. Epub 2021 Jun 11. Annu Rev Nutr. 2021. PMID: 34115517
285 results